Yu, Xue Qin https://orcid.org/0000-0001-8638-7979
Goldsbury, David
Feletto, Eleonora
Koh, Cherry E.
Canfell, Karen
O’Connell, Dianne L.
Article History
Received: 29 July 2021
Accepted: 10 November 2021
First Online: 25 November 2021
Declarations
:
: KC is co-principal investigator of an investigator-initiated trial of cytology and primary HPV screening in Australia (“Compass”), which is conducted and funded by the VCS Foundation, a government-funded health promotion charity. VCS has received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana USA. However neither KC, nor her institution on her behalf (Cancer Council NSW) has received direct or indirect funding from industry for Compass or any other project. No other conflict of interests is declared.
: The 45 and Up Study was approved by the University of NSW Human Research Ethics Committee (HREC 05035/HREC 10186). This analysis was covered by ethics approval from the NSW Population and Health Services Research Ethics Committee (HREC/14/CIPHS/54).